Evelo Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Evelo Biosciences

14/08/2023 14:33

* Evelo Biosciences Inc  EVLO.OQ  reported a quarterly
adjusted
loss of $3.78​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of $3.30 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Evelo Biosciences Inc's reported EPS for the quarter was a
loss
of $3.78​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Evelo Biosciences Inc shares had risen by 209.5% this
quarter and lost 68.8% so far this year.
    * The company reported a quarterly loss of $21.1 million.
    * Wall Street's median 12-month price target for Evelo
Biosciences
Inc is $15.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -3.30          -3.78          Missed
 Mar. 31 2023      -3.16          -4.60          Missed
 Dec. 31 2022      -5.52          -4.20          Beat
 Sep. 30 2022      -6.70          -5.60          Beat